Related Experiment Video
Updated: May 15, 2026

08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
von Willebrand Factor multimers profiling with a semi-automated system
Fabio Pasotti1, Giuliana Martini, Luigi Caimi
1Department of Diagnostics, Spedali Civili of Brescia, Brescia, Italy.
Electrophoresis
|January 22, 2013
Summary
Diagnosing von Willebrand disease (vWD) involves complex tests. A new semi-automated method significantly speeds up von Willebrand factor (vWF) multimer analysis, aiding in vWD subclassification.
Area of Science:
- Hematology
- Clinical Chemistry
- Biochemistry
Background:
- Von Willebrand disease (vWD) diagnosis relies on assessing plasma von Willebrand factor (vWF) concentration and function.
- Phenotypic testing, specifically multimer pattern analysis, is crucial for classifying hereditary and acquired vWD subtypes.
- Current multimer analysis is technically challenging, time-consuming (3-4 days), and performed in limited specialized laboratories.
Purpose of the Study:
- To develop a rapid, sensitive, and semi-automated method for visualizing vWF multimeric structure.
- To standardize and simplify the technical difficulties associated with vWF multimer analysis.
- To reduce the turnaround time for vWF multimer testing.
Main Methods:
- Developed a semi-automated electrophoresis technique for patient plasma vWF.
- Utilized precast gels compatible with G26 Interlab instrumentation for 120-minute electrophoresis.
- Employed gel blotting for direct visualization of vWF multimer patterns on a membrane.
Main Results:
- Significantly reduced the total assay time from 72 hours to 8 hours.
- Achieved sensitive visualization of vWF multimeric structures.
- The method is suitable for routine laboratory use and standardization.
Conclusions:
- The developed semi-automated method offers a faster and more accessible approach to vWF multimer analysis.
- This technique can overcome technical challenges and reduce assay duration.
- Proposed for first-level screening of von Willebrand factor multimer deficiency.

